It was first FDA-approved in 2010 under the brand name Egrifta for HIV-associated lipodystrophy, a condition causing excess visceral fat accumulation
This 92-person trial is the closest thing to a head-to-head decomposition of the combination that exists, and its most interesting result is the negative one: on the primary glycaemic endpoint, adding cagrilintide to semaglutide did not produce a statistically significant improvement over semaglutide alone
Your naturally occurring GLP-1 plays a role in your blood sugar levels, but it also impacts your digestion
People looking for better results may want advice on building meals and managing daily routines
It is estimated that athletes can consume up to 300 mg of L-carnitine per day
Other cardiovascular adverse effects that have been reported include hypertension, ischemic events, palpitations, and sinus tachycardia